Jehangir Khan

Title: Jehangir Khan: Innovator in Antibacterial Compounds

Introduction

Jehangir Khan is a prominent inventor based in Edmonton, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibacterial agents. With a total of nine patents to his name, Khan's work has the potential to impact the treatment of bacterial infections.

Latest Patents

Among his latest patents are innovative bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors. These compounds are defined by a specific formula, where M can be hydrogen or a pharmaceutically acceptable salt-forming cation. The compounds also include variations where Y is either OR or NRR, with R, R, and M being defined within the patent documentation. Additionally, Khan's patents cover methods of treating bacterial infections, pharmaceutical compositions, molecular complexes, and processes for preparing these compounds.

Career Highlights

Throughout his career, Jehangir Khan has worked with notable companies such as Fedora Pharmaceuticals Inc. and Naeja Pharmaceutical Inc. His expertise in the pharmaceutical industry has allowed him to develop groundbreaking solutions to combat bacterial infections.

Collaborations

Khan has collaborated with esteemed colleagues, including Samarendra N Maiti and Dai Q Nguyen. These partnerships have further enhanced his research and development efforts in the field of antibacterial agents.

Conclusion

Jehangir Khan's innovative work in the development of antibacterial compounds showcases his dedication to improving healthcare solutions. His contributions through patents and collaborations highlight the importance of research in combating bacterial infections.